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Abstract – Mycoplasma mycoides subsp. mycoides SC (MmmSC) is the etiological agent of contagious
bovine pleuropneumonia (CBPP). Although eradicated in most developed countries, the disease reappeared
in Europe in the 1990s. This reappearance may have been caused either by importation from sub-Saharan
Africa, where CBPP is still endemic, or by the reemergence of virulent strains in Europe, as suggested
by earlier studies. A multilocus sequence analysis scheme has been developed to address this issue and,
most importantly, to be able to monitor new epidemics. The alignment of the full genome sequence of
the reference strain PG1 and the partial genome sequence of a pathogenic strain allowed the identification
of polymorphic sites. Nineteen initial loci were selected within housekeeping genes, genes of unknown
function and non coding sequences. The suitability of these loci for genotyping MmmSC strains was first
tested on six strains of diverse geographic origin. The analyses showed that the published PG1 sequence
contained a number of specific polymorphisms that were therefore of no use for molecular typing. Among
the eight informative polymorphic loci finally selected, only one (ftsY) was positioned within a housekeep-
ing gene. Three main groups and 31 diﬀerent allelic profiles were identified among 51 strains and strain
variants examined. Cluster analysis confirmed that European strains from the 1990s did not originate from
Africa. It also showed a genetic link between a European strain isolated in 1967 and those found in southern
Africa and Australia. This was in agreement with historical data showing that CBPP was introduced in these
regions during colonisation in the 19th century.
Mycoplasma mycoides / contagious bovine pleuropneumonia / multilocus sequence analysis / molecu-
lar epidemiology
1. INTRODUCTION
Mycoplasma mycoides subsp. mycoides SC
(MmmSC) is the etiological agent of conta-
gious bovine pleuropneumonia (CBPP) [33].
This disease belongs to the list of notifiable
animal diseases from the World Organisation
for Animal Health (OIE) because of its eco-
* Corresponding author: thiaucourt@cirad.fr
nomic importance (http://www.oie.int). CBPP
induces lesions of pneumonia and pleurisy
in cattle and domestic buﬀaloes and, without
treatment, mortality rates can reach up to 50%.
CBPP gained a worldwide distribution as a
result of live animal trade in the middle of
the 19th century [11]. The disease was pro-
gressively eradicated from many countries in
Europe and North America on the eve of the
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20th century thanks to the strict application
of stamping out policies. A strategy that com-
bined vaccination campaigns, detection and
slaughter of infected animals and control of
animal movements allowed Australia to regain
a CBPP-free status in 1973 [8]. In sub-Saharan
Africa, CBPP was eradicated in the extreme
southern part of Africa but remains enzootic
elsewhere. The disease was under control in
Africa around 1980, when repeated vaccina-
tion campaigns were organised to eradicate
rinderpest by use of bivalent vaccines that also
provided protection against CBPP. However,
its prevalence and distribution have extended
dramatically since the eradication of rinder-
pest in 1993, which implies that no more
vaccination campaigns have been organised
and subsidised [25]. European countries are
now free of CBPP, though some of them have
experienced sporadic outbreaks at regular in-
tervals. This was the case in Portugal, where
CBPP outbreaks were reported in 1935, 1953,
and 1993. Outbreaks were also reported at the
border between Spain and France in 1967 and
1982, and in Italy in 1993 [34]. On each oc-
casion, field epidemiological inquiries failed
to yield clues regarding the origin of the out-
breaks and did not permit to elucidate whether
they were the result of reintroduction or resur-
gence of the disease.
MmmSC, the agent of CBPP, belongs to
the so-called Mycoplasma mycoides cluster,
which includes six mycoplasma subspecies
and groups of strains that are closely related
from both a phenotypic and a genetic point
of view [9, 10]. The organisms most closely
related to MmmSC are M. mycoides subsp. my-
coides LC (MmmLC) and M. mycoides subsp.
capri (Mmc), which are both etiological agents
of contagious agalactia in small ruminants. Re-
cent data have shown that these two subspecies
could be grouped into a single entity [45]. Dif-
ferentiation of the strains belonging to these
three taxons is diﬃcult when relying only
on the standard growth inhibition technique.
Concerning intra-species polymorphism, com-
parative studies by SDS-PAGE have already
shown that strain variability within MmmSC
is much more limited than within MmmLC
and Mmc [9]. Although MmmSC is thought to
be a very homogeneous taxon, previous stud-
ies have shown that MmmSC strains could
be diﬀerentiated using molecular typing as-
says. Analysis of genomic polymorphism by
endonuclease restriction of whole genomic
DNA showed that diﬀerent profiles were ob-
tained with BamHI and PstI [31] and that the
profiles corresponding to European strains dif-
fered from those of African origin. The use
of HindIII allowed distinguishing various vac-
cine strains [40]. The evidence of multiple
copies of insertion elements present in the
MmmSC genome allowed the development of
new typing tools based on Southern blot hy-
bridisation. The use of IS1296 as a probe
allowed the clear diﬀerentiation of recent Eu-
ropean strains from those of African origin [7].
The observed diﬀerence was explained later on
by the identification of an 8.8 kbp deletion in
the genome of most MmmSC strains of Euro-
pean origin [43], resulting in a missing IS1296
band. The use of another insertion element,
IS1634, also led to diﬀerent Southern blot pro-
files [24, 46] although the high copy number
of this insertion sequence (N = 60), as com-
pared to that of IS1296 (N = 28), gave rise to
profiles that were diﬃcult to analyse. The use
of a technique based on sequencing multiple
loci, designated multilocus sequence analysis
(MLSA), allowed the identification of 15 dif-
ferent allelic profiles within a representative
number of MmmSC strains (N = 48) of var-
ious origins [22]. In 2004 the whole genome
sequence of MmmSC reference strain PG1 was
published [48], opening new opportunities for
the development of typing tools. Analysis of
the PG1 genome sequence showed that the
loci and primer pairs previously selected for
MLSA were not the most adequate. Some of
the primers hybridised on multiple sites, whilst
other targeted sequences were duplicated in
the PG1 genome, hampering result interpreta-
tion. Comparison of PG1 sequences with the
sequences of a pathogenic MmmSC strain, ob-
tained through an ongoing genome sequencing
project, allowed the identification of a num-
ber of polymorphic sites. The objective of this
study was to select a set of polymorphic loci
to develop a more precise and robust MLSA
scheme in order to type MmmSC strains from
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Table I. List of strains.
Profiles Strains Origin Locality Year of Comments References Provided by
isolation
A00 Gemu Gofa Ethiopia Turmi? 1974 NVI Dr Fikre
A00 83162 Chad Bougor? 1983 CIRAD
A01 91130 CAR Bouar? 1991 LCV Bangui, Dr Condolas
A02 Afadé Cameroon Afade 1965 LaboFarcha Dr Provost
A02 Vom Nigeria Vom? 1965 Sheep orign Vom Laboratory
A03 B17 Chad N’Djamena 1959 LaboFarcha Dr Balis
A04 8740 Cameroon Touroua 1987 [50] LANAVET, Garoua Dr Tulasne
A04 8740-Rita Cameroon Garoua 1987 8740 after LANAVET, Garoua Dr Yaya
passage on cattle
A04 8740/11 Cameroon Touroua 1987 11th passage CIRAD
A04 8740/53 Cameroon Touroua 1987 53rd passage CIRAD
A04 98029 Benin Kandi? 1998 Dr Hendrikx
A04 9048 Nigeria Sokoto? 1990 Labocel Niamey Dr Bloch
A05 Muguga Kenya Athi-river 1997 [47] KARI, Muguga, Dr Wesonga
A05 95014 Tanzania Shinyanga? 1995 FAO Dr Provost
A05 94111 Rwanda Kigali 1994 Action Nord-Sud, Mme Isakov
A06 2000-033 Ethiopia Gimbi 2000 NVRIC Sebata, Dr Sentayou
A07 7721 Mauritania Tiguent 1997 CNERV, Nouakchott, Dr Brun
A08 96010 Mauritania Noukchott? 1996 NVRIC Sebata, Dr Sentayou
A09 Fatick Senegal Fatick 1968 IEMVT (CIRAD)
A10 99042 Mali Kolokani? 1999 LCR Bamako, Dr Niang
A11 2000-005 Burkina Faso Ouagadougou? 2000 LDRV, Ouagadougou, Dr Bado
A12 2003-036 Mali Segou? 2001 LCV Bamako, Dr Niang
A12 87137-10 Burkina Faso Banfora 1987 LDRV, Ouagadougou, Dr Rouille
A12 98011 Ivory Coast ? 1998 LCPA Bingerville, Dr Cissé
A12 9050-529-1 Ivory Coast Korhogo? 1990 LCPA Bingerville Dr Domenech
B01 8988-1 Namibia Oudangwa 1989 CVL Windhoek, Dr Hehnen
B02 97039 Namibia Rundu? 1994 CVL Windhoek, Dr Huebschle
B02 97041 Botswana Nata? 1995 CVL Windhoek, Dr Huebschle
all over the world and to elucidate the molecu-
lar epidemiology of CBPP.
2. MATERIALS AND METHODS
2.1. MmmSC strains and isolates
Table I lists the names and origin of the
51 strains and strain variants of MmmSC used in this
study. The strains, selected in order to cover the en-
tire geographic distribution of CBPP, were isolated
from Africa (N = 41), Europe (N = 5), Australia
(N = 2), and India (N = 1), whereas the origin of
strains Lederle, Asmara, and PG1 is unknown. The
oldest strain of known origin was isolated in 1936
(strain V5 from Australia) and the most recent in
2004 (strain 2004-003 from Zambia). The date of
isolation of six strains was not precisely known. Al-
though the majority of the isolates were of bovine
origin, a few isolates from small ruminants (Vom,
94158 and 99048) were also included.
Strains were grown in a modified Hayflick
medium containing sodium pyruvate and glu-
cose [39]. At the end of the exponential phase
of growth, 2 mL of culture were centrifuged at
12 000 × g for 15 min at 4 ◦C. The pellet was
washed once in PBS, and re-suspended in 100 µL
of distilled water, to which 150 µL of lysis buﬀer
(100 mM Tris HCl, pH 8.5; 0.05% Tween 20;
0.24 mg/mL proteinase K) were added. Following
incubation at 60 ◦C for 30 min, proteinase K was
heat-inactivated at 95 ◦C for 5 min. Samples in lysis
buﬀer were stored at –20 ◦C until analysis and they
were added to the PCR mix without further DNA
extraction.
2.2. Identification of suitable loci for MLSA
Partial genomic sequences of the MmmSC
pathogenic strain 8740-Rita, obtained from an on-
going whole genome sequencing project, were
used to evaluate the polymorphism existing be-
tween this strain and the reference strain PG1
(NC_005364). Although the final assembly of the
8740-Rita genome has not yet been obtained, the
available contigs encompassed most of the DNA
(page number not for citation purpose) Page 3 of 19
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Table I. Continued.
Profiles Strains Origin Locality Year of Comments References Provided by
isolation
B02 97038 Botswana ? 1995 [1] CVL Windoek, Dr Huebschle
B03 T2/34 Tanzania Morogoro? 1956 CIRAD
B03 99048 India Izatnagar? 1999 Goat origin [38] IVRI, Izatnagar, Dr Srivastava
B03 Gladysdale Australia Gladysdale < 1965 CIRAD
B03 Pillai Sudan Malakal? 1960 CIRAD
B04 2004-003 Zambia Sesheke 2004 FAO Dr Amanfu
B05 V5 Australia ? 1938 Vaccine [6] CIRAD
B06 Asmara Eritrea Asmara unknown Vaccine CIRAD
B07 99021 Tanzania T1/B 1999 T1 variant [47] CIRAD
B07 T1sr Tanzania Korogwe? 1951 Vaccine CIRAD
C01 94158 Portugal ? 1994 [5] LNIV, Lisboa Dr Brandao
C01 PO2 France Pyrennees 1981 CIRAD
C01 99065 Italy Brescia 1992 IZS Teramo Dr Pini
C02 9335-170 Italy ? 1992 IZS Teramo Dr Santini
C03 PO1967 France Pyrennees 1967 CIRAD
D01 97009 Ethiopia Makale 1997 NVI Dr Berhe
D02 2003-011 Eritrea Assab? 2003 MOA Asmara, Dr Tesfaalem
E01 DK32 Senegal Dakar unknown Vaccine [32] CIRAD
E02 9373-804 Guinea Kankan? 1993 LDV Conakry, Dr Condé
F01 PG1 Unknown ? < 1931 Reference strain CIRAD
G01 Lederle Unknown Puigcerda? < 1967 Vaccine CIRAD
H01 Filfili Senegal Filfili 1965 CIRAD
I01 KH3J Sudan Juba < 1948 Vaccine [16] CIRAD
Localities followed by a ? were chosen to obtain a geographic positionning. CAR = Central African Re-
public; CIRAD = centre de coopération internationale en recherche agronomique pour le développement;
CVL = central veterinary laboratory; FAO = food and agriculture organisation; IVRI = Indian veterinary research
institute; IZS = instituto zooprofilactico sperimentale; KARI = Kenya agricultural research institute; LABO-
CEL = laboratoire central d’élevage; LANAVET = laboratoire national vétérinaire; LCPA = laboratoire central
de pathologie animale; LCV = laboratoire central vétérinaire; LDRV = laboratoire départemental de recherche
vétérinaire; LDV = laboratoire de diagnostic vétérinaire; LNIV = laboratorio nacional de investigacao veteri-
naria; MOA = ministry of agriculture; NVI = national veterinary institute; NVRI = national veterinary research
institute.
sequences homologous to PG1. Only insertion se-
quences and large duplicated zones in the PG1
genome, unsuitable for MLSA, were excluded. As
a whole, 800 kbp were available for comparison.
Alignments were performed using the AlignX pro-
gram of Vector NTI software (Vector NTI v10.3.0,
Invitrogen corporation, Carlsbad, CA, USA). Poly-
morphic sites were recorded and positioned in the
PG1 genomic sequence map. Nineteen polymorphic
positions were chosen for initial validation. Seven
of them resided in housekeeping genes, six within
lipoprotein or transmembrane protein genes and a
further six within non-coding sequences and they
were all distributed along the entire PG1 genome, as
shown in Figure 1. The suitability of these loci for
MLSA was first validated by sequencing the homol-
ogous regions of five additional MmmSC strains:
the original PG1 strain used for genome sequenc-
ing in Sweden and four other strains from Europe
(PO1967), East Africa (94111), West Africa (Fil-
fili), and Australia (Gladysdale). Eight potentially
interesting loci were then chosen for final validation
using the whole set of strains (Tab. II).
2.3. PCR and sequencing
PCR was carried out in a 50 µL reaction contain-
ing: 0.5 unit of Taq DNA polymerase (Qiagen SA,
Courtaboeuf, France) in its corresponding buﬀer
(including 1.5 mM MgCl2), 300 µM of dTTP and
dATP, 150 µM of dGTP and dCTP, 0.4 µM of each
primer and 1 µL of sample diluted 1/100. Amplifi-
cations were performed using GeneAmp PCR Sys-
tems 2400 and 9700 (Perkin Elmer, Courtaboeuf,
France). Thermal cycling consisted in an initial de-
naturation step at 94 ◦C for 5 min, followed by
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Figure 1. Distribution of polymorphic positions in the PG1 genome (NC_005364) and loci used for MLSA.
Polymorphic positions are identified giving the corresponding CDS number in the PG1 sequence. The loci
retained for the final MLSA scheme are boxed.
35 cycles of denaturation at 94 ◦C for 15 s, an-
nealing at 52 ◦C for 30 s and extension at 72 ◦C
for 90 s. The final extension step was maintained
at 72 ◦C for 7 min. The size and purity of the
amplicons were controlled by electrophoretic sepa-
ration in 1% agarose gels and samples with relevant
features were sent to Genome Express (Genome
Express Cogenics, Meylan, France) for sequencing
with the corresponding primers. Both forward and
reverse strands were sequenced systematically.
2.4. Allelic profile analysis
The sequences obtained from each correspond-
ing forward and reverse primers were assembled us-
ing Vector NTI SuiteTM (InfoMax, 2001) and the ex-
tremities corresponding to single strand sequences
or showing aberrant features were trimmed. The
sequences obtained from diﬀerent strains for each
locus were aligned using ClustalW (Vector NTI).
Polymorphic sites were recorded, carefully check-
ing the corresponding sequence chromatograms. A
new allele number was assigned to each change in
the nucleotide sequence. In the end, each strain was
characterised by an allelic profile, corresponding to
the combination of allele numbers for each of the
eight selected loci. This resulted in a matrix com-
prising 31 diﬀerent allelic profiles (Tab. III), which
was analysed using eBURST V3, a software devel-
oped for the analysis of multilocus sequence typing
(MLST) datasets1. Standard parameters were used,
except for the number of loci, which was fixed at
eight. Each strain was then characterised by a letter,
corresponding to its group, followed by a number,
corresponding to the allelic profile.
2.5. Molecular epidemiology analysis
When the exact origin of the strain was known,
the geographic coordinates were inferred from a
dedicated website2. When this information was not
available, a putative geographic location was as-
signed to the strain, taking into account the known
distribution of CBPP in the country. For example,
strains originating from Namibia were positioned
north of the veterinary fence that separates CBPP
1 http://eburst.mlst.net/v3/
2 http://earthsearch.net/intSearch/
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Table II. List of primers used for PCR and sequencing. The positions refer to the nucleotide sequence
NC_005364 of reference strain PG1.
Loci names Gene Primers Position Sequences (5’- 3’) Amplicon size
(bp)
Loc-PG1-0001 nc Loc-PG1-0001-F 1272 AACAAAAGAGATCTTAAATCACACTTTA 538Loc-PG1-0001-R 1809 CCTCTTGTTTAACTTCTAGATCAGAAT
Loc-PG1-0103 Lpp Loc-PG1-0103-D 121796 GATGGATATAATCTATACTAGCATTTA 1321Loc-PG1-0103-F 123116 CCTTATATAGATAAAACTCCTCCTTA
Loc-PG1-0287 nc Loc-PG1-0287-F 328750 GATTGCTTTAATCAATTTCTTACTGA 545Loc-PG1-0287-R 329294 GGATAACCTTGATTTTTTATTTGCTTTA
Loc-PG1-0431 Lpp Loc-PG1-0431-F 485201 CAATTCTTTAAATTTGGGTTTGTT 608Loc-PG1-0431-R 485808 CTTGCAAGAGTATTTAGATTTGATTAAA
Loc-PG1-0489 ftsY Loc-PG1-0489-F 555289 GTTAGTTGTTGAAATGTTAGATAT 756Loc-PG1-0489-R 556044 CCCATATCAGTTTGGATTAA
Loc-PG1-0523 Chp Loc-PG1-0523-F 597315 ACAGCATTTGATCAAGATTTAAGTAGTT 824Loc-PG1-0523-R 598138 TTACCTAGGTGTTTAAAACTTCATTTG
Loc-PG1-0710 Hp Loc-PG1-0711 –F 816093 CCAGTTGAACCATTTATTTTATATATACCT 643Loc-PG1-0711-R 816735 AAATATAAGTGGTGCTGGAATAACA
Loc-PG1-0827 nc Loc-PG1-0827-F 940048 AGTTGTACAACTGTATGAATCTATGATTAT 619Loc-PG1-0827-R 940666 CAGGATATACTTCAAAAATTAAAGGTTT
Lpp: Lipoprotein, Chp: conserved hypothetical protein, Hp: hypothetical protein, nc: non coding sequence.
infected regions in the North from CBPP-free zones
in the South. Strains were then positioned on a map,
displaying group and allele numbers.
3. RESULTS
3.1. Choice of MLSA loci and initial validation
The first objective of this study was to find
suitable loci for multilocus sequence analy-
sis of MmmSC strains. Nineteen polymorphic
sites observed by comparing the genome se-
quence of MmmSC reference strain PG1 with
the partial genome sequence of pathogenic
strain 8740-Rita were chosen for initial valida-
tion. Five strains, including the original PG1
used for genome sequencing in Sweden and
four other strains from diverse geographic ori-
gins, were used for this initial validation.
Two loci were considered unsuitable be-
cause the polymorphisms that were initially
observed between PG1 and 8740-Rita were
apparently due to errors in the published PG1
sequence. In Loc-PG1-0330 (lepA) both the
G in position 379030 and the T in position
379050 are actually A. These two modifica-
tions result in a single amino acid modification
in the deduced protein sequence. In Loc-PG1-
0191 (trsE), the T in position 227175 should
be deleted and a T should be inserted after
position 227214. These changes modify sig-
nificantly the sequence of the trsE product
(12 amino acids). Interestingly, when this lo-
cus was sequenced in the vaccine strain T1/44,
an insertion sequence (IS1634) was found in-
terrupting the trsE gene at position 227363.
The putative function of the trsE gene product
is not well known, though it may be involved
in the transport of large molecules, intracel-
lular traﬃcking and secretion. The disruption
of trsE in strain T1/44 indicates that this gene
is not essential, though whether this has con-
tributed to the attenuation of the vaccine strain
is yet to be elucidated. Four additional loci
were excluded as the polymorphism was found
to be limited to the sequence of strain PG1,
whereas the other five MmmSC strains exhib-
ited identical sequences. Three of these loci
where located within the housekeeping genes
fusA (Loc-PG1-0159), glpK (Loc-PG1-0258),
and rpoB (Loc-PG1-1008), whereas Loc-PG1-
0372 corresponded to a non-coding sequence.
Another four loci (Loc-PG1-0145, Loc-PG1-
0194, Loc-PG1-0456, and Loc-PG1-0750)
were eliminated because they did not add to
the discriminatory power of Loc-PG1-0489.
Loc-PG1-0233 was also excluded, since only
Page 6 of 19 (page number not for citation purpose)
Molecular epidemiology of CBPP by MLSA Vet. Res. (2008) 39:14
Ta
bl
e
II
I.
M
at
rix
sh
ow
in
g
th
e
v
ar
io
u
s
al
le
lic
pr
o
fil
es
o
bt
ai
n
ed
th
ro
u
gh
M
LS
A
an
al
ys
is
o
ft
he
ei
gh
tl
o
ci
.
Pr
ofi
le
s
Ty
pe
Lo
c-
PG
1-
00
01
Lo
c-
PG
1-
01
03
Lo
c-
PG
1-
02
87
Lo
c-
PG
1-
04
31
Lo
c-
PG
1-
04
89
Lo
c-
PG
1-
05
23
Lo
c-
PG
1-
07
10
Lo
c-
PG
1-
08
27
st
ra
in
s
A
00
G
em
u
G
o
fa
1
2
1
1
2
1
1
1
A
01
91
13
0
5
2
1
1
2
1
1
1
A
02
A
fa
dé
1
3
1
1
2
1
1
1
A
03
B
17
1
3
1
1
2
1
1
2
A
04
87
40
4
3
1
1
2
1
1
1
A
05
M
u
gu
ga
.
1
1
1
1
2
1
1
1
A
06
20
00
/0
33
1
1
1
1
3
1
1
1
A
07
77
21
1
2
4
1
2
1
1
1
A
08
96
01
0
2
2
4
1
2
1
1
1
A
09
Fa
tic
k
1
2
4
1
4
1
1
1
A
10
99
04
2
1
2
4
1
2
2
1
1
A
11
20
00
/0
05
2
2
4
1
2
2
1
1
A
12
87
13
7
3
2
4
1
2
2
1
1
B
01
C8
98
8
1
3
1
1
4
3
2
1
B
02
97
00
39
1
2
1
1
4
3
2
1
B
03
G
la
dy
sd
al
e
1
2
1
5
4
3
2
1
B
04
20
04
/0
03
1
4
1
1
4
3
2
1
B
05
V
5
1
3
1
5
4
3
2
1
B
06
A
sm
ar
a
1
3
1
1
4
3
1
1
B
07
T1
SR
1
5
1
1
4
3
1
1
C0
1
94
15
8
1
2
1
1
5
5
2
2
C0
2
93
35
1
2
1
2
5
5
2
2
C0
3
PO
19
67
1
2
1
1
5
3
2
2
D
01
97
00
9
4
2
1
1
4
3
1
1
D
02
20
03
/0
11
4
2
1
1
4
3
1
2
E0
1
D
K
32
3
2
1
1
1
1
1
1
E0
2
93
73
/8
04
3
3
1
1
1
1
1
1
F0
1
PG
1
1
2
5
6
6
3
2
2
G
01
Le
de
rlé
6
1
3
4
4
4
2
3
H
01
Fi
lfi
li
4
1
2
1
1
1
1
1
I0
1
K
H
3J
1
2
1
3
4
1
1
1
(page number not for citation purpose) Page 7 of 19
Vet. Res. (2008) 39:14 A. Yaya et al.
two alleles could be defined in this sequence.
All strains of European origin, and none of the
other, bore allele 2 in this locus, making it a
good tag for this origin. It must be noted that
PG1, the origin of which is unknown, also dis-
played allele 2 in this locus. On the contrary,
strain Lederle, which had been used as a vac-
cine in Spain, displayed allele 1, suggesting
that it may not be of European origin. Finally,
in Loc-PG1-0194, three alleles were defined,
though the results were redundant and did not
allow a better diﬀerentiation of the strains. In
the end, eight loci were selected (Tab. II) to
perform MLSA on the whole set of MmmSC
strains.
Interestingly, analysis of sequence varia-
tions amongst MmmSC strains showed that
many coding sequences (CDS) were inter-
rupted in PG1, whereas larger CDS were iden-
tified in the other MmmSC strains. This was
the case of four out of the eight selected loci.
The CDS MSC_0103 and MSC_0104 con-
stituted a single CDS of around 370 amino
acids, as well as MSC_0287 and MSC_0288,
forming a single CDS of 713 amino acids,
and MSC_0710 and MSC_0711, which con-
stituted a single CDS of 934 amino acids. The
CDS MSC_0827 was extended from 99 to
344 amino acids.
3.2. Robustness of the MLSA
To evaluate the robustness of the method,
cultures of pathogenic strain 8740, the same
strain at the 11th and 53rd passages and af-
ter a passage in bovines (8740-Rita), were
analysed. These were considered variants of
the same strain, diﬀering only by a few, well
characterised, in vitro or in vivo passages. In
addition, three strains (94111, Filfili, Gladys-
dale) were tested in duplicate at three months
of interval. No diﬀerences were evidenced ei-
ther between the duplicates or between the
four strain variants diﬀering in the number of
passages. This result was important to show
that the selected loci were stable over a few
passages, implying that the sequence diﬀer-
ences were correlated to the natural evolution
of the strains in vivo. In the case of high muta-
tion rates the signal would be blurred or biased
through in vitro passage, whereas in the case
of low mutation rates the loci would have been
unsuitable for use as molecular epidemiology
tools.
3.3. Alleles defined in the diﬀerent loci
3.3.1. Alleles defined in non-coding sequences
Five alleles were defined in locus Loc-PG1-
0287. Two alleles gathered the majority of the
strains (46 out of 51), with allele 4 found only
in Western Africa, while allele 1 had no geo-
graphic specificity.
Three alleles were defined in locus Loc-
PG1-0827. Forty-one strains bore the same al-
lele. The other alleles corresponded to strains
found in Europe and Africa, as well as PG1.
Six alleles were defined in Loc-PG1-0001,
with the greatest variability found among
strains from West Africa.
3.3.2. Alleles defined in genes of unknown
function: Lipoproteins (Lpp) and
Conserved hypothetical proteins (Chp)
The smallest number of alleles was 2 for
locus Loc-PG1-0710. The observed mutation
induced an amino acid modification in the pre-
dicted putative lipoprotein (L to S). There was
a clear geographic segregation of the alleles
(Fig. 2). With the exception of strain Pillai, all
strains found in inter-tropical Africa bore al-
lele 1.
Four diﬀerent alleles were defined in Loc-
PG1-0523. However, some MmmSC strains
could not be typed, as this locus was located
within the 8.8 kbp deletion that was found
to be specific to recent European strains. A
fifth allele was therefore created in order to
type this last group of strains using eBURST.
Interestingly, the only strain of European ori-
gin for which this locus could be sequenced,
PO1967, bore the same allele as the strains
found in southern Africa and Australia. This
allele was characterised by six polymorphic
positions that diﬀered in other MmmSC strains
(Tab. IV). This gave more strength to the ge-
netic link demonstrated by this allele.
Five alleles were defined in locus Loc-PG1-
0103. They corresponded to a variable number
of five to nine trinucleotide repeats (AAT) cod-
ing for asparagine (N) within a gene coding for
Page 8 of 19 (page number not for citation purpose)
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a putative lipoprotein. There was no apparent
geographic segregation of the various alleles.
3.3.3. Allele defined in the housekeeping gene
ftsY
Six alleles were defined in Loc-PG1-0489,
corresponding to ftsY. The majority of the
strains were segregated in two alleles, com-
prising similar numbers (23 and 18 strains
respectively). Allele 2 was found only on
MmmSC strains from sub-Saharan origin. Al-
lele 4 was displayed by strains from Southern
Africa, Australia, and India, as well as by some
strains from East Africa. It was also found on
one old strain from West Africa and a strain of
unknown origin (Lederle), which was formerly
used as a vaccine in Europe.
All strains isolated in Europe bore allele 5
on this locus (Fig. 3), strain Lederle, formerly
used as a vaccine in Spain, has an unknown
origin.
3.4. Strain groups by MLSA analysis
All 51 strains were characterised by an al-
lelic profile and 31 diﬀerent allelic profiles
were identified (Tab. III). The genetic events
underlying the description of the various alle-
les are described in Table IV. Analysis using
eBURST allowed the identification of three
main groups of strains (comprising 43 strains).
Eight strains were included into groups gath-
ering only two strains or considered as sin-
gletons. The geographic positioning of the
various groups and allelic profiles is shown in
Figure 4.
Group A was the largest, including 25
strains (Fig. 5). Thirteen diﬀerent allelic
profiles were clustered within this group.
The largest (A04 and A12) gathered up to
four strains. Group A strains were found
mostly in West and central Africa, though
some of them were found in East Africa
(Fig. 4). It must be noted that all MmmSC
strains isolated after 1994 in East Africa pre-
sented the same allelic profile (A05).
Group B was the second largest, including
13 strains that were subdivided into 7 allelic
profiles (Fig. 6). Group B strains were found
in southern Africa, East Africa, Australia and
India (Fig. 4). The most common allelic pro-
file (B03) was shared by four strains of various
origins (Australia, Tanzania, Sudan, and In-
dia). Most of group B strains found in East
Africa had been isolated before 1970 (Pillai,
T1sr, T2-34, and a vaccine strain received
from a laboratory at Asmara, the origin of
which remains undetermined).
Group C corresponded to strains found
solely in Europe (Fig. 4 and 6).
Finally, eight strains could not be included
into any of the three main groups, as they dis-
played peculiar allelic profiles. In West Africa
peculiar profiles corresponded to old strains
isolated in Senegal and Guinea and in East
Africa to a vaccine strain (KH3J) also isolated
long ago. Two strains isolated recently from
northern Ethiopia and Eritrea also bore pecu-
liar allelic profiles. Finally, PG1 was the strain
that exhibited the most peculiar allelic profile.
4. DISCUSSION
4.1. Genomic analysis
The objective of this study was to estab-
lish a more robust MLSA scheme for MmmSC
strains based on whole genome sequence com-
parison. Analysis of PG1 sequences showed
that many primers designed on a previous
MLSA scheme [22] hybridised at multiple
sites or targeted sequences that were dupli-
cated in the PG1 genome. The initial valida-
tion of 19 selected loci in this study revealed
that sequencing errors may remain in the pub-
lished PG1 genome. Out of the 19 initial poly-
morphic loci, two corresponded to sequencing
errors. It must be noted that, if this result
was extrapolated to the 267 polymorphic sites
found between the sequences of strains PG1
and 8740-Rita, there may be around 20 errors
in the published PG1 sequence. Another four
out of the 19 polymorphic positions seemed
to be specific to the PG1 sequence. The pe-
culiarity of the PG1 genome has already been
shown. For example, this strain possesses a
large DNA repeat of 24 kbp, which is absent
in other MmmSC strains [3]. The peculiari-
ties of PG1 may be due to a natural diver-
gent evolution of the strain. However, it is
diﬃcult to substantiate this hypothesis, since
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Figure 5. Tree obtained by eBURST for group A strains. Group A is subdivided into 13 allelic profiles and
gathers strains found only in sub-Saharan Africa. The largest allelic profile (A12) comprises four strains.
However, these strains were collected in neighbouring countries on well known cattle trade routes. This is
a likely explanation for finding strains of similar allelic profiles at diﬀerent locations.
Figure 6. Tree obtained by eBURST for group B and C strains. Group B is subdivided into seven allelic
profiles and gathers strains found in Southern and East Africa, as well as strains isolated in Australia and
India. Group C gathers European strains. Strain PO1967 is an intermediate between group B and group C.
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the exact origin and year of isolation (be-
fore 1931) of the strain are unknown. More
likely, the divergence of PG1 may result from
the many in vitro passages. A single house-
keeping gene (ftsY) was validated for use in
the new MLSA scheme. It was noteworthy that
polymorphisms in this gene included the pres-
ence of duplicated nonanucleotides coding for
a stretch of three amino acids (DQQ) present
in three to five copies, as well as the deletion of
a rather long DNA fragment (35 bp). Since this
gene, coding for a bacterial signal-recognition
particle receptor, plays a fundamental role in
mediating membrane targeting and insertion of
nascent proteins [2], it is likely that the poly-
morphic sites are not positioned on the active
sites of this molecule.
4.2. Epidemiological analysis
The presence of group A strains only in
West and central Africa may indicate that these
strains have evolved separately from those
present in Europe. This may also indicate that
CBPP existed in the continent prior to coloni-
sation and presumed introduction of CBPP
with live cattle. Such a hypothesis was already
raised when a traditional “vaccination” pro-
cedure, consisting in inoculating pleural fluid
subcutaneously at the bridge of the nose, was
described in West Africa [4]. The local inflam-
mation generally led to a reaction of the pe-
riosteum, with development of a pseudo-horn,
which resulted in the erroneous description of
a new cattle breed called Bos triceros [35].
These traditional procedures were unknown in
Europe, where the inoculation point, as de-
scribed by Willems, was the tip of the tail [49].
Furthermore, a possible ancestral allelic pro-
file (A00) was identified in strains isolated in
Chad and the Gemu-Gofa region in Western
Ethiopia. In these regions the influx of exotic
cattle was minimal in the 19th century. In con-
trast, the presence of group B strains in East
Africa could reflect an influx of aﬀected cat-
tle from Europe. This may have taken place
directly from European countries (i.e. from
Italy to its Eritrean colony) or indirectly, as
when the 1868 British expedition to Abyssinia
used oxcarts from India to pull artillery in the
mountainous regions [19] and might have thus
introduced CBPP in East Africa.
The geographic location of strains sharing
the same allelic profile agreed with known
epidemiological data. Therefore, the presence
of multiple strains with the same allelic pro-
file certainly does not result from an MLSA
lack of discriminatory power. For example,
the presence of allelic profile A05 in many
countries in Eastern Africa can be explained
by a ‘clonal expansion’ of the initial strain of
Kenyan origin that led to the re-contamination
of countries such as Tanzania and Rwanda in
the 1990s [25]. Similarly, the presence of the
same allelic profile (A12) in Mali, Burkina
Faso, and Ivory Coast is in agreement with
the transhumance and trade routes followed by
cattle herds that are raised in Sahelian coun-
tries and exported to meat markets near large
cities in the South.
Although strain PO1967, of European ori-
gin, belongs to group C, its sequence in Loc-
PG1-0233 showed that it is closely related to
Group B strains. The localisation of Group
B strains in this MLSA scheme corroborated
what was known regarding the transmission of
CBPP from Europe to overseas colonies dur-
ing the 19th century. It is well known that
CBPP was exported from Europe to South-
ern Africa [41], Australia [15, 28], and In-
dia [36] at that time. The European strain
linked to this group, PO1967, is the oldest
strain from our collection, which was iso-
lated in 1967 on the French-Spanish border.
This strain may represent the closest rela-
tive to the ancestral strains that circulated in
Europe in the 19th century. More recent Eu-
ropean strains diﬀer from PO1967 notably by
a deletion of 8.8 kbp, which includes genes
encoding a glycerol transporter that may be as-
sociated with MmmSC virulence [30, 44]. Un-
fortunately MmmSC strains circulating prior to
1967 in Europe are not available. They could
have been used to monitor the genetic drift
and to check if they were genetically closer to
MmmSC strains of Southern Africa.
Recent strains of European origin displayed
peculiar alleles that were not observed in
non-European strains, notably on Loc-PG1-
0233 which was not retained in the MLSA
(page number not for citation purpose) Page 15 of 19
Vet. Res. (2008) 39:14 A. Yaya et al.
scheme. This finding indicates further that re-
cent CBPP outbreaks in Europe were not due
to a reintroduction, but were more likely to be
a resurgence of the disease. This conclusion
should be of major concern to European coun-
tries, particularly with regards to the widening
of EU borders. The unnoticed persistence of
MmmSC in Europe may be explained either
by the existence of another, yet unidentified,
reservoir or by the circulation of strains of low-
pathogenicity, which may sometimes regain
virulence. The presence of MmmSC strains in
hosts other than cattle and domestic buﬀaloes
has already been described. This is notably
the case of goats, from which MmmSC strains
have been regularly isolated both in Africa
and in Europe and in which lesions of CBPP
can sometimes be reproduced [13]. In an at-
tempt to examine whether goats may be used
in place of cattle as models for CBPP, various
inoculation routes were tested by Yaya et al.
[51]. Some inoculated goats seroconverted and
one animal, inoculated intra-peritoneally, de-
veloped lesions. However, the role of goats in
the natural epidemiology of CBPP is certainly
marginal, if not completely irrelevant. This
was evidenced in Botswana in 1994, when this
country decided to slaughter the entire cattle
population from the infected zone [27]. Al-
though the goat population was not targeted
in the stamping-out campaign, the subsequent
reintroduction of naive cattle in this country
was not followed by CBPP outbreaks, hence
showing that goats did not play a significant
role in CBPP persistence and long term trans-
mission, at least in this context.
On the contrary, the unnoticed circulation
of low-pathogenic MmmSC strains in Europe
remains a possible explanation for the resur-
gence of CBPP. It is well known that MmmSC
strains show various degrees of virulence.
However, strain virulence is diﬃcult to mea-
sure since (i) there is no small animal model
that can mimic the lesions observed in cat-
tle, (ii) endobronchial inoculations in cattle are
not always successful, even when using strains
that have shown to be highly virulent in the
field, and (iii) in-contact transmission trials
are usually carried out with a reduced num-
ber of animals, which may not guarantee the
evaluation of the strain virulence in a single
experiment. This last point has been verified
in silico with stochastic transmission models
showing that successive trials performed with
the same initial parameters may lead to very
diﬀerent outcomes [21].
MLST is an unambiguous procedure for
characterising isolates of bacterial species
based on the sequences of the internal frag-
ments of house-keeping genes [23, 37]. The
sequences of approximately 500 bp are nor-
mally used, as these can be accurately se-
quenced on both strands using an automated
DNA sequencer. For each house-keeping gene,
the diﬀerent sequences present within a bac-
terial species are assigned as distinct alleles
and each isolate is characterised by an allelic
profile, corresponding to the alleles defined
in each of the loci. In MLST analyses the
number of nucleotide diﬀerences found be-
tween alleles is disregarded and sequences are
given diﬀerent allele numbers whether they
diﬀer at a single or at many nucleotide po-
sitions. The rationale for this is that a single
genetic event resulting in a new allele can
occur by a point mutation, altering only a sin-
gle nucleotide site, or by a recombinational
replacement that will often result in the mod-
ification of multiple sites. This typing scheme
has been applied successfully to a wide variety
of bacterial pathogens such as Staphylococcus
aureus [14], Campylobacter jejuni [12], and
Haemophilus influenzae [26], to cite only a
few. This approach has multiple applications
such as phylogeny [18], molecular structure
analysis [42], and molecular epidemiology. In
molecular epidemiology, MLST can be used
to study the evolution of antibiotic resistant
strains [17], the temporal trends in strain ex-
pansion [29], or the distribution of strains of
various lineages within a population [20].
In the case of MmmSC, this approach was
not successful, since the variability within
housekeeping genes was too limited, if present
at all. This was the case of the genes fusA,
lepA, and rpoB. In terms of an evolutionary
perspective this may indicate that MmmSC
genomes are extremely homogeneous, sug-
gesting that this mycoplasma has adapted very
recently to its bovine host. From a practical
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point of view, this means that genes of un-
known function or non coding sequences had
to be selected in this study to diﬀerentiate
MmmSC strains. This is why the strategy
has alternatively been named “multilocus se-
quence analysis”. This typing scheme is less
universal than MLST analyses, since the gene
targets used were selected for typing strains
within a biotype and would not be suitable
for typing strains of higher taxonomic ranks.
However, like MLST, MLSA has the advan-
tage of being a portable and very robust ap-
proach.
This new MmmSC typing scheme proved
more robust than the previous one developed
in our laboratory [22]. No double bands were
obtained after PCR amplification, which en-
sured that PCR products could be sent without
any purification step. This was sometimes the
case with the previous MLSA. On the contrary,
the new scheme allowed the description of 31
profiles instead of only 15 out of a comparable
number of strains (51 and 48 respectively).
MLSA analysis may open new perspec-
tives for a better understanding of MmmSC
genome plasticity. In this respect, it would be
very interesting to obtain ancestral DNA from
samples of CBPP-aﬀected lungs preserved in
formalin for histology. This should allow the
characterisation of the ancestral allelic profiles
circulating in Europe and Africa and may per-
mit measuring evolution rates for the various
loci.
This MLSA strategy may also be applied
to better understand CBPP epidemiology, im-
proving thus the surveillance and control of
the disease. New loci may be added to in-
crease the discriminating power of the MLSA
tool on subsets of strains that are very closely
related. Including a large number of strains
isolated from goats in various regions of the
world would be very interesting in order to ex-
amine whether the MLSA profiles of MmmSC
strains from goat origin are similar or, on
the contrary, more closely related to other
MmmSC strains circulating in the same re-
gion. The fact that caprine species may serve
as a reservoir should be an incentive to mul-
tiply mycoplasma isolation and identification
from this host, which is known to harbour my-
coplasmas in the ear canal in the absence of
pathological signs. Such a procedure is already
in place in France, conducted by an epidemi-
ological network called VIGIMYC, managed
by the Agence Française de Sécurité Sanitaire
des Aliments in Lyon.
The results obtained in this study will be
included in a web tool dedicated to molecular
epidemiology within an EU-funded project
called EPIZONE. This tool should facilitate
the dissemination of typing methods for
pathogens threatening Europe, allow any
laboratory to compare in-house data with
large databank sets and, in turn, generate
phylogenetic trees and actualised maps,
provided that the geographic coordinates of
all isolates are known. Such a tool should
naturally be linked to the websites of the OIE
(http://www.oie.int/wahid-prod/) and FAO
(http://www.fao.org/ag/againfo/programmes/
en/empres/disease_cbpp.asp), which provide
updated information on new outbreaks for
notifiable diseases.
Finally, this new MLSA tool will be par-
ticularly useful to all countries at risk of
CBPP reintroduction or resurgence and to
those engaged in eradication campaigns, al-
lowing them to trace back the origin of any
remaining CBPP focus.
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